Ampio Pharmaceuticals, Inc. (AMPE) Financial Statements (2025 and earlier)
Company Profile
Business Address |
9800 MOUNT PYRAMID COURT, SUITE 400 ENGLEWOOD, CO 80112 |
State of Incorp. | DE |
Fiscal Year End | December 31 |
Industry (SIC) | 2834 - Pharmaceutical Preparations (benchmarking) |
More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) (USD)
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | 12/31/2017 | |||
---|---|---|---|---|---|---|---|---|---|
ASSETS | |||||||||
Current Assets | |||||||||
Cash, cash equivalents, and short-term investments | 12,653,000 | 33,892,000 | 17,346,000 | 6,532,000 | 7,585,392 | 8,220,469 | |||
Cash and cash equivalents | 12,653,000 | 33,892,000 | 17,346,000 | 6,532,000 | 7,585,392 | 8,209,071 | |||
Short-term investments | 11,398 | ||||||||
Prepaid expense | 13,000 | 68,000 | 69,000 | 531,000 | |||||
Deferred costs | |||||||||
Derivative instruments and hedges, assets | 12,000 | ||||||||
Other undisclosed current assets | 663,000 | 1,672,000 | 1,078,000 | 1,187,000 | 413,280 | 210,417 | |||
Total current assets: | 13,329,000 | 35,632,000 | 18,493,000 | 8,250,000 | 7,998,672 | 8,442,886 | |||
Noncurrent Assets | |||||||||
Operating lease, right-of-use asset | 75,000 | 629,000 | 824,000 | 1,003,000 | ✕ | ✕ | |||
Property, plant and equipment | 184,000 | 2,564,000 | 3,561,000 | 4,748,000 | 5,997,582 | 6,837,861 | |||
Deposits noncurrent assets | 33,856 | 33,856 | |||||||
Total noncurrent assets: | 259,000 | 3,193,000 | 4,385,000 | 5,751,000 | 6,031,438 | 6,871,717 | |||
TOTAL ASSETS: | 13,588,000 | 38,825,000 | 22,878,000 | 14,001,000 | 14,030,110 | 15,314,603 | |||
LIABILITIES AND EQUITY | |||||||||
Liabilities | |||||||||
Current Liabilities | |||||||||
Accounts payable and accrued liabilities, including: | 852,000 | 4,811,000 | 1,550,000 | 4,025,000 | 1,324,651 | 2,785,529 | |||
Employee-related liabilities | ✕ | ✕ | 389,000 | 72,000 | |||||
Accounts payable | 97,000 | 427,000 | 186,000 | 151,000 | |||||
Accrued liabilities | 334,000 | 731,000 | 420,000 | 368,000 | |||||
Other undisclosed accounts payable and accrued liabilities | 421,000 | 3,264,000 | 944,000 | 3,434,000 | 1,324,651 | 2,785,529 | |||
Debt | 284,000 | 259,000 | |||||||
Deferred rent credit | 59,579 | ✕ | |||||||
Deferred revenue and credits | ✕ | ✕ | ✕ | ✕ | ✕ | ✕ | 59,579 | ||
Other undisclosed current liabilities | 340,000 | 311,000 | 1,033,261 | ||||||
Total current liabilities: | 1,192,000 | 5,122,000 | 1,834,000 | 4,284,000 | 1,384,230 | 3,878,369 | |||
Noncurrent Liabilities | |||||||||
Long-term debt and lease obligation: | 614,000 | 925,000 | 1,210,000 | ||||||
Liabilities, other than long-term debt | 607,000 | 5,805,000 | 2,607,000 | 2,064,000 | 7,409,784 | 45,613,119 | |||
Deferred revenue and credits | ✕ | ✕ | ✕ | ✕ | ✕ | ✕ | 537,364 | ||
Deferred rent credit | 476,753 | ✕ | |||||||
Asset retirement obligations | 289,000 | ||||||||
Operating lease, liability | 274,000 | 614,000 | 925,000 | 1,210,000 | ✕ | ✕ | |||
Derivative instruments and hedges, liabilities | 44,000 | 5,805,000 | 2,607,000 | 2,064,000 | 6,933,031 | 45,075,755 | |||
Total noncurrent liabilities: | 607,000 | 6,419,000 | 3,532,000 | 3,274,000 | 7,409,784 | 45,613,119 | |||
Total liabilities: | 1,799,000 | 11,541,000 | 5,366,000 | 7,558,000 | 8,794,014 | 49,491,488 | |||
Equity | |||||||||
Equity, attributable to parent, including: | 11,789,000 | 27,284,000 | 17,512,000 | 6,443,000 | 5,236,096 | 34,200,000 | |||
Common stock | 2,000 | 23,000 | 19,000 | 16,000 | 11,094 | 8,006 | |||
Additional paid in capital | 245,726,000 | 244,863,000 | 218,020,000 | 191,060,000 | 176,227,510 | 170,803,783 | |||
Accumulated deficit | (233,939,000) | (217,602,000) | (200,527,000) | (184,633,000) | (171,002,508) | (204,988,674) | |||
Other undisclosed equity, attributable to parent | 68,376,885 | ||||||||
Other undisclosed equity | (68,376,885) | ||||||||
Total equity: | 11,789,000 | 27,284,000 | 17,512,000 | 6,443,000 | 5,236,096 | (34,176,885) | |||
TOTAL LIABILITIES AND EQUITY: | 13,588,000 | 38,825,000 | 22,878,000 | 14,001,000 | 14,030,110 | 15,314,603 |
Income Statement (P&L) (USD)
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | 12/31/2017 | ||
---|---|---|---|---|---|---|---|---|
Operating expenses | (22,318,000) | (20,571,000) | (15,834,000) | (18,576,000) | (11,183,962) | (15,564,956) | ||
Other operating income, net | 45,170,128 | |||||||
Operating income (loss): | (22,318,000) | (20,571,000) | (15,834,000) | (18,576,000) | 33,986,166 | (15,564,956) | ||
Nonoperating income (expense) | 5,981,000 | 3,496,000 | (60,000) | 4,946,000 | (36,326,989) | |||
Investment income, nonoperating | 5,761,000 | 3,492,000 | (543,000) | 4,869,000 | (36,218,832) | |||
Income (loss) from continuing operations: | (16,337,000) | (17,075,000) | (15,894,000) | (13,630,000) | 33,986,166 | (51,891,945) | ||
Income (loss) before gain (loss) on sale of properties: | ✕ | ✕ | (17,075,000) | (15,894,000) | (13,630,000) | 33,986,166 | (51,891,945) | |
Net income (loss) attributable to parent: | (16,337,000) | (17,075,000) | (15,894,000) | (13,630,000) | 33,986,166 | (51,891,945) | ||
Preferred stock dividends and other adjustments | (3,492,000) | (4,869,065) | ||||||
Other undisclosed net loss available to common stockholders, basic | (5,761,000) | |||||||
Net income (loss) available to common stockholders, diluted: | (22,098,000) | (20,567,000) | (15,894,000) | (18,499,065) | 33,986,166 | (51,891,945) |
Comprehensive Income (USD)
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | 12/31/2017 | ||
---|---|---|---|---|---|---|---|---|
Net income (loss): | (16,337,000) | (17,075,000) | (15,894,000) | (13,630,000) | 33,986,166 | (51,891,945) | ||
Comprehensive income (loss), net of tax, attributable to parent: | (16,337,000) | (17,075,000) | (15,894,000) | (13,630,000) | 33,986,166 | (51,891,945) |
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.